Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › New Iberia › NPI 1285601088
Hospital

Hospital Service District No. 1 of Iberia Parish

Hospital Service District No. 1 of Iberia Parish was paid $20.42M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is 99284, emergency room visit (serious) — 22% of everything it billed.

33Billing provider infoHOSPITAL SERVICE DISTRICT NO. 1 OF IBERIA PARISH
NEW IBERIA, LA 70560
33aNPI1285601088assigned 03/01/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$20.42M
24GClaims786,591
24DCodes billed160
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#23 of 96
Median peer was paid$5.17M
This provider vs. median4.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201897,348$1.88M
201990,088$1.74M
202090,500$1.69M
2021112,633$2.91M
2022136,056$3.87M
2023157,568$4.57M
2024incomplete102,398$3.76M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 22% 42,617 37,597 $4.54M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 22% 27,414 23,809 $4.50M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 56,105 50,168 $4.10M
80050 General health panel 2.8% 16,157 14,488 $582K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2.8% 19,257 16,825 $567K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.4% 34,077 27,805 $494K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.4% 12,009 10,739 $481K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 22,529 18,125 $449K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.8% 8,715 5,719 $366K
71046 Radiologic examination, chest; 2 views 1.8% 20,521 18,175 $364K
80053 Comprehensive metabolic panel 1.6% 53,932 45,273 $331K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.5% 20,443 17,557 $312K
148 more codes
96375 Therapeutic injection; each additional sequential IV push 1.5% 15,626 $301K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 56,095 $261K
87430 1.0% 15,677 $210K
87400 <1% 33,847 $173K
36415 Collection of venous blood by venipuncture <1% 87,019 $171K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 604 $132K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 3,778 $125K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,801 $118K
81025 <1% 17,646 $113K
87070 <1% 13,996 $101K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 870 $98K
81001 <1% 48,305 $93K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 19,159 $78K
70450 Computed tomography, head or brain; without contrast material <1% 652 $77K
80061 Lipid panel <1% 7,096 $76K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 333 $73K
41899 Unlisted procedure, dentoalveolar structures <1% 162 $62K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,011 $60K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 954 $60K
87088 <1% 9,662 $58K
84484 <1% 8,950 $57K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,568 $53K
G0378 Hospital observation service, per hour <1% 969 $49K
84443 Thyroid stimulating hormone (TSH) <1% 3,316 $41K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,361 $40K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,358 $40K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,121 $33K
J7030 Infusion, normal saline solution , 1000 cc <1% 13,603 $32K
83690 <1% 6,751 $32K
77067 Screening mammography, bilateral, including computer-aided detection <1% 932 $29K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 995 $29K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,105 $26K
86780 <1% 1,914 $22K
83721 <1% 4,263 $22K
96417 <1% 1,045 $21K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,173 $20K
71045 Radiologic examination, chest; single view <1% 1,040 $19K
83036 Hemoglobin; glycosylated (A1C) <1% 2,415 $19K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 897 $16K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 114 $16K
96523 <1% 963 $16K
J7050 Infusion, normal saline solution, 250 cc <1% 4,615 $13K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 196 $13K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 352 $12K
87420 <1% 895 $11K
74019 <1% 361 $10K
83970 <1% 420 $10K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 746 $10K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 29 $9K
83735 <1% 2,398 $9K
84439 <1% 1,076 $8K
83880 <1% 374 $8K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,534 $7K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 15 $7K
82550 <1% 1,713 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,563 $6K
96361 Intravenous infusion, hydration; each additional hour <1% 362 $6K
85027 <1% 1,465 $6K
82553 <1% 950 $5K
82728 <1% 540 $5K
80069 <1% 1,029 $5K
82533 <1% 324 $4K
C1769 Guide wire <1% 76 $4K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 17 $4K
77063 Screening digital breast tomosynthesis, bilateral <1% 716 $4K
96415 <1% 189 $4K
80320 <1% 1,271 $3K
82570 <1% 1,117 $3K
84100 <1% 1,116 $3K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 516 $3K
86850 <1% 652 $3K
95811 <1% 30 $3K
82746 <1% 253 $2K
82378 <1% 238 $2K
83615 <1% 694 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,108 $2K
84156 <1% 1,136 $2K
80048 Basic metabolic panel (calcium, ionized) <1% 491 $2K
87077 <1% 398 $2K
71250 <1% 12 $2K
87186 <1% 394 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 25 $2K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 14 $2K
86803 <1% 130 $2K
86900 <1% 648 $2K
85045 <1% 567 $2K
83550 <1% 260 $1K
72100 <1% 92 $1K
82607 <1% 128 $1K
83540 <1% 287 $1K
86901 <1% 655 $1K
86592 <1% 309 $1K
87340 <1% 126 $1K
86762 <1% 73 $892.18
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 335 $810.36
73562 <1% 41 $738.24
81003 <1% 212 $716.21
86787 <1% 63 $660.59
73610 <1% 25 $648.10
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 211 $624.42
73630 <1% 38 $601.55
86140 <1% 148 $559.44
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,739 $530.22
90715 <1% 27 $492.55
85660 <1% 102 $479.37
82043 <1% 138 $445.06
73130 <1% 14 $437.03
85651 <1% 142 $435.18
85730 <1% 142 $414.27
82962 <1% 171 $393.89
85610 <1% 193 $390.34
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,736 $320.06
82040 <1% 149 $311.87
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 223 $305.36
87449 <1% 33 $287.52
73030 <1% 36 $275.10
80055 <1% 12 $255.14
85379 <1% 45 $244.32
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,593 $243.15
J1790 Injection, droperidol, up to 5 mg <1% 58 $224.33
82950 <1% 56 $215.83
84704 <1% 18 $183.48
74018 <1% 12 $156.48
87631 <1% 832 $142.63
87040 <1% 14 $134.16
96376 <1% 17 $131.84
J2550 Injection, promethazine hcl, up to 50 mg <1% 58 $128.98
90686 <1% 15 $126.42
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 70 $67.93
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 47 $60.16
84550 <1% 19 $54.24
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 255 $50.40
99214 Doctor's office visit, returning patient (more involved) <1% 101 $50.12
87075 <1% 16 $37.88
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 130 $32.10
J2060 Injection, lorazepam, 2 mg <1% 13 $26.52
85347 <1% 14 $21.00
90853 Group psychotherapy (other than of a multiple-family group) 0% 1,623 $0.00
T1015 A visit at a community health center or clinic (one all-in rate) 0% 281 $0.00
00170 Anesthesia for intraoral procedures, including biopsy 0% 469 $0.00
G0177 Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) 0% 868 $0.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 247 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 73 $0.00
81002 0% 14 $0.00
00126 0% 148 $0.00
G0410 Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes 0% 752 $0.00
99213 Doctor's office visit, returning patient (routine) 0% 172 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTEMPLETON, PARKER (PRESIDENT/CHIEF EXECUTIVE OFFICER)